Internal Medicine, Endocrinology, Diabetes, & Metabolism · Jonesboro, AR
NPI
1699730762
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4802 E Johnson Ave
Jonesboro, AR, 72401
Phone (870) 936-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
3,195 services
Medicare patients, 2024
837
Average age 71
Drug cost, 2024
$2.3M
8,028 prescriptions
Company payments, 2025
$444
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin D Ganong was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 739 times for 626 patients. In total Kevin D Ganong billed 3,195 services in 29 codes, and Medicare paid $82K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 739 | 626 | $11.08 | $8,186 |
| 99213 Office E&M - Established | Office | 450 | 419 | $56.05 | $25K |
| 99214 Office E&M - Established | Office | 295 | 263 | $78.09 | $23K |
| 99204 Office E&M - New | Office | 156 | 156 | $101.63 | $16K |
| 95251 Test - Miscellaneous | Office | 82 | 80 | $24.50 | $2,009 |
| 99221 Hospital E&M - Initial | Facility | 33 | 33 | $55.40 | $1,828 |
| 99231 Hospital E&M - Subsequent | Facility | 30 | 20 | $34.31 | $1,029 |
| 36415 Venipuncture Blood Collection | Office | 28 | 23 | $8.65 | $242 |
| 76536 Ultrasound - Nonspecific | Office | 19 | 19 | $63.42 | $1,205 |
| 99203 Office E&M - New | Office | 18 | 18 | $78.59 | $1,415 |
By year: 2022 $93K for 5,238 services; 2023 $76K for 4,567 services; 2024 $82K for 3,195 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 28 | 23 | $8.65 | $242 |
Medicare prescription drug claims, 2024
In 2024, the drug Kevin D Ganong prescribed most often to Medicare patients was Levothyroxine Sodium, with 796 prescriptions and refills. In total Kevin D Ganong wrote 8,028 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 796 | 1,537 | 172 | $5,241 |
| Methimazole Generic | 516 | 899 | 100 | $5,720 |
| Metformin Hcl Generic | 403 | 758 | 88 | $1,994 |
| Pioglitazone Hcl Generic | 350 | 674 | 84 | $2,795 |
| Ozempic Semaglutide | 284 | 353 | 56 | $327K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 214 | 313 | 54 | $35K |
| Metformin Hcl Er Metformin Hcl | 185 | 424 | 48 | $1,337 |
| Glimepiride Generic | 181 | 369 | 50 | $981 |
| Farxiga Dapagliflozin Propanediol | 167 | 255 | 32 | $140K |
| Humalog Kwikpen U-100 Insulin Lispro | 157 | 191 | 41 | $35K |
| Novolog Flexpen Insulin Aspart | 156 | 223 | 42 | $40K |
| Mounjaro Tirzepatide | 151 | 171 | 41 | $179K |
| Glipizide Er Glipizide | 134 | 264 | 27 | $1,634 |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 128 | 153 | 35 | $124K |
| Testosterone Cypionate Generic | 124 | 152 | 22 | $3,492 |
Brand drugs: 3,363 claims; generic drugs: 4,081 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin D Ganong $444 ($444 in general payments such as food, travel and fees) from 8 companies. The largest payer was Novo Nordisk Inc with $95.13.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.